Skip to content

BALLIGAND: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

BALLIGAND

BE 0437.257.291
NACE 47.730, Retail sale of pharmaceutical products
financial year 2024 against 2025filed annual accounts (NBB)
Net result for the year
-€33,907
2024 · -€4,476-€29,431
Equity
€91,369
2024 · €125,277-€33,907
Cash
€41,163
2024 · €53,864-€12,702
Balance sheet total
€205,868
2024 · €230,142-€24,274

Largest movements

2024 to 2025
Assets
  • Stocks and contracts -€13,530

    down €13,530 (-15.0%), from €90,080 to €76,550

  • Cash -€12,702

    down €12,702 (-23.6%), from €53,864 to €41,163

    mainly Net result for the year (-€33,907) and Trade debts (-€14,265)

  • Tangible fixed assets +€6,389

    up €6,389 (+22.2%), from €28,778 to €35,167

    of which Plant, machinery and equipment: +€7,066

  • Receivables within one year -€5,400

    down €5,400 (-20.3%), from €26,584 to €21,185

    of which Trade receivables: -€5,321

Equity and liabilities
  • Profit (loss) carried forward -€33,907

    down €33,907 (-23.0%), from -€147,278 to -€181,186

  • Other debts +€26,960

    up €26,960 (+1432.0%), from €1,883 to €28,843

  • Trade debts -€14,265

    down €14,265 (-47.3%), from €30,129 to €15,864

  • Tax, wage and social debts -€3,061

    down €3,061 (-4.2%), from €72,854 to €69,793

    of which Remuneration and social security: -€3,500

Income statement
  • Staff costs +€38,330

    up €38,330 (+45.3%), from €84,567 to €122,897

  • Gross operating margin +€10,954

    up €10,954 (+13.1%), from €83,499 to €94,452

  • Financial income -€3,830

    down €3,830 (-100.0%), from €3,830 to €0

  • Financial charges -€2,623

    down €2,623 (-71.7%), from €3,658 to €1,036

  • Depreciation +€1,317

    up €1,317 (+83.0%), from €1,587 to €2,904

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 -€4,476
Gross operating margin +€10,954
Staff costs -€38,330
Depreciation -€1,317
Other operating charges +€485
Financial income -€3,830
Financial charges +€2,623
Taxes -€15
Result 2025 -€33,907

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€3,410
Investment -€9,292
Financing €0
Cash 2024 €53,864
Net result for the year -€33,907
Depreciation +€2,904
Stocks and contracts +€13,530
Receivables within one year +€5,400
Deferred charges and accrued income -€970
Trade debts -€14,265
Tax, wage and social debts -€3,061
Other debts +€26,960
Investment in fixed assets (net) -€9,292
Current investments +€0
Cash 2025 €41,163
Every line side by side 46 lines
Line Code 2024 2025 Change %
Total assets 20/58 €230,142 €205,868 -€24,274 -10.5%
Fixed assets 21/28 €28,778 €35,167 +€6,389 +22.2%
Tangible fixed assets 22/27 €28,778 €35,167 +€6,389 +22.2%
Land and buildings 22 €16,981 €16,981 = 0.0%
Plant, machinery and equipment 23 €10,786 €17,852 +€7,066 +65.5%
Furniture and vehicles 24 €1,012 €334 -€678 -67.0%
Current assets 29/58 €201,363 €170,701 -€30,662 -15.2%
Stocks and contracts in progress 3 €90,080 €76,550 -€13,530 -15.0%
Stocks 30/36 €90,080 €76,550 -€13,530 -15.0%
Amounts receivable within one year 40/41 €26,584 €21,185 -€5,400 -20.3%
Trade receivables 40 €26,506 €21,185 -€5,321 -20.1%
Other amounts receivable 41 €78 - -€78
Current investments 50/53 €28,182 €28,182 -€0 0.0%
Cash at bank and in hand 54/58 €53,864 €41,163 -€12,702 -23.6%
Deferred charges and accrued income 490/1 €2,653 €3,622 +€970 +36.5%
Total equity and liabilities 10/49 €230,142 €205,868 -€24,274 -10.5%
Equity 10/15 €125,277 €91,369 -€33,907 -27.1%
Contributions 10/11 €260,000 €260,000 = 0.0%
Capital 10 €260,000 €260,000 = 0.0%
Issued capital 100 €260,000 €260,000 = 0.0%
Reserves 13 €12,555 €12,555 = 0.0%
Non-distributable reserves 130/1 €7,350 €7,350 = 0.0%
Legal reserve 130 €7,350 €7,350 = 0.0%
Distributable reserves 133 €5,205 €5,205 = 0.0%
Profit (loss) carried forward 14 -€147,278 -€181,186 -€33,907 -23.0%
Amounts payable 17/49 €104,865 €114,499 +€9,634 +9.2%
Amounts payable within one year 42/48 €104,865 €114,499 +€9,634 +9.2%
Trade debts 44 €30,129 €15,864 -€14,265 -47.3%
Suppliers 440/4 €30,129 €15,864 -€14,265 -47.3%
Taxes, remuneration and social security 45 €72,854 €69,793 -€3,061 -4.2%
Taxes 450/3 €132 €570 +€438 +333.3%
Remuneration and social security 454/9 €72,723 €69,223 -€3,500 -4.8%
Other amounts payable 47/48 €1,883 €28,843 +€26,960 +1432.0%
Remuneration, social security and pensions 62 €84,567 €122,897 +€38,330 +45.3%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €1,587 €2,904 +€1,317 +83.0%
Other operating charges 640/8 €1,832 €1,347 -€485 -26.5%
Gross operating margin 9900 €83,499 €94,452 +€10,954 +13.1%
Operating profit (loss) 9901 -€4,487 -€32,695 -€28,208 -628.7%
Financial income 75/76B €3,830 €0 -€3,830 -100.0%
Recurring financial income 75 €3,830 €0 -€3,830 -100.0%
Financial charges 65/66B €3,658 €1,036 -€2,623 -71.7%
Recurring financial charges 65 €3,658 €1,036 -€2,623 -71.7%
Profit (loss) for the period before taxes 9903 -€4,315 -€33,731 -€29,416 -681.7%
Income taxes 67/77 €161 €177 +€15 +9.6%
Profit (loss) for the period 9904 -€4,476 -€33,907 -€29,431 -657.5%
Profit (loss) for the period to be appropriated 9905 -€4,476 -€33,907 -€29,431 -657.5%

Source: filed annual accounts (NBB), financial years ended 30 June 2024 and 30 June 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 11 October 2026 via checked.be.